HERA

Dec 23 2024HEALTH

Seizure Control: A New Implant Combines Quick Zaps and Slow-Release Drugs

Epilepsy is a tough nut to crack. Doctors often use meds or deep brain stimulation to tackle seizures, but these methods have their limits. Some people don't respond well to meds, and seizures can be unpredictable. Recently, scientists have come up with new ways to tackle these challenges, like resp

reading time less than a minute
Dec 22 2024HEALTH

Sickle Cell and Men: Handling Unwanted Erections

Sickle cell disease, a hereditary condition, can cause some tough challenges for men, especially when it comes to priapism. Priapism is a condition where men experience prolonged erections without sexual arousal, and it's more than just uncomfortable—it can lead to significant health issues if not m

reading time less than a minute
Dec 22 2024HEALTH

Ginseng: A Natural Ally Against Chemo's Heart Impact

Chemotherapy is a game-changer in the fight against cancer. But it can also have some nasty side effects on the heart, like making it weak or causing it to beat irregularly. Doctors often tweak the dose or switch to different treatments to avoid these issues. But what if a natural plant could lend a

reading time less than a minute
Dec 22 2024SCIENCE

Pretty Plants, Powerful Potions: How Changing Celosia argentea's DNA Boosts its Appeal

Celosia argentea is a plant that's not only attractive but also useful in medicine. As more people appreciate these multi-purpose plants, finding ways to make them even more appealing could open up new markets. Changing the DNA of these plants, a process called polyploidization, can help achieve thi

reading time less than a minute
Dec 22 2024HEALTH

Rethinking Albendazole Treatment for Parasitic Diseases in China

Echinococcosis is a nasty disease caused by parasites. In China, a medicine called albendazole is given for free to people with this disease under a government program. This study aims to see how well people are taking their medicine and how effective it is. By doing this, we hope to boost the numbe

reading time less than a minute
Dec 22 2024HEALTH

Why Parenteral Nutrition is Key in Helping Patients with Severe Pancreatitis

When a person experiences severe acute pancreatitis, it becomes a challenging health condition. This illness often involves multiple organ failures and high rates of infections, leaving patients at risk for serious complications. While early enteral nutrition (feeding through the gut) is typically t

reading time less than a minute
Dec 21 2024HEALTH

Hormone Therapy and Breast Cancer: What Women Think

Women going through postmenopause and suffering from early-stage breast cancer often rely on hormone therapy (HT) to delay cancer's return. But HT comes with side effects that can take a toll on their overall well-being. There's a way to make it better, though. A mix of exercise and health education

reading time less than a minute
Dec 21 2024HEALTH

Can Chemo After Surgery Really Help Biliary Cancer Patients?

Biliary tract cancers are known for their high recurrence rates, even after successful surgery. This makes the future look quite grim for those diagnosed. One common approach to reduce this recurrence risk is to use adjuvant chemotherapy (ACT) after surgery. ACT aims to target and destroy any tiny c

reading time less than a minute
Dec 21 2024HEALTH

New Hope for Advanced Biliary Tract Cancer: Combining Nivolumab with Chemotherapy

Advanced biliary tract cancer (BTC) is a tough nut to crack. Doctors often turn to second-line treatments like 5-fluorouracil (5FU) and liposomal irinotecan when first-line therapies fail. These drugs have shown promise in improving survival rates. But what if we could make them even more effective?

reading time less than a minute
Dec 21 2024HEALTH

School Enrollment After ACTH Therapy for Infantile Epilepsy Patients

Infantile epileptic spasms syndrome (IESS) can lead to serious brain development issues. But how does this affect kids' chances of going to elementary school? This study looked into that, focusing on kids who got adrenocorticotropic hormone (ACTH) therapy. ACTH therapy is a common treatment for IES

reading time less than a minute